Indoco Remedies gets EIR from USFDA for 2 plants in Goa
Drug firm Indoco Remedies on Friday said it has received establishment inspection report from the US health regulator for its sterile facility and solid dosages facility in Goa. The inspection was held from May 27-June 4, 2019 and the company received four Form 483 observations, Indoco Remedies said in a filing to BSE.
"We are happy to receive the EIR in less than two months from the date of inspection," Indoco Remedies MD Aditi Kare Panandikar said.
This is encouraging, as the site has been endorsed with the Voluntary Action Indicated (VAl) status twice this year, by the United States Food and Drug Administration (USFDA), she added.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!